Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome

Mark O. Goodarzi, Michelle R. Jones, Heath J. Antoine, Marita Pall, Yii Der I. Chen, Ricardo Azziz

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Context: Increased androgen production is a primary feature of polycystic ovary syndrome (PCOS) and appears to be an inherited trait. The gene for the steroidogenic enzyme type 5 17β hydroxysteroid dehydrogenase (HSD17B5) was implicated as a candidate for the hyperandrogenemia of PCOS by a previous study that demonstrated an association of a single nucleotide polymorphism (SNP) in the promoter of this gene with PCOS. Objective: The objective of the study was to replicate the previous report of association between the HSD17B5 gene and PCOS risk by genotyping the promoter SNP (as well as other SNPs in the region to provide improved coverage of the gene) in a large, well-characterized cohort suitable for replication study. Design: Women with and without PCOS were genotyped for five SNPs in HSD17B5. SNPs and haplotypes were determined and tested for association with PCOS risk and phenotypic markers of PCOS. Setting: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; controls were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles. Participants: Participants included 287 white women with PCOS and 187 white controls. Main Measurements: HSD17B5 genotype, PCOS risk, and testosterone levels were measured. Results: No SNP or haplotype was significantly associated with PCOS risk, testosterone, or any of the traits tested. Conclusions: These data suggest that polymorphisms in the HSD17B5 gene are not associated with PCOS risk or elevated testosterone as previously reported.

Original languageEnglish (US)
Pages (from-to)300-303
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume93
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Polycystic Ovary Syndrome
Polymorphism
Genes
Testosterone
Single Nucleotide Polymorphism
Nucleotides
Endocrinology
Androgens
Haplotypes
3(17)-hydroxysteroid dehydrogenase
Los Angeles
Enzymes
Genotype

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome. / Goodarzi, Mark O.; Jones, Michelle R.; Antoine, Heath J.; Pall, Marita; Chen, Yii Der I.; Azziz, Ricardo.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 93, No. 1, 01.01.2008, p. 300-303.

Research output: Contribution to journalArticle

Goodarzi, Mark O. ; Jones, Michelle R. ; Antoine, Heath J. ; Pall, Marita ; Chen, Yii Der I. ; Azziz, Ricardo. / Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome. In: Journal of Clinical Endocrinology and Metabolism. 2008 ; Vol. 93, No. 1. pp. 300-303.
@article{31c04c34993d4da299093696fbf8aef2,
title = "Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome",
abstract = "Context: Increased androgen production is a primary feature of polycystic ovary syndrome (PCOS) and appears to be an inherited trait. The gene for the steroidogenic enzyme type 5 17β hydroxysteroid dehydrogenase (HSD17B5) was implicated as a candidate for the hyperandrogenemia of PCOS by a previous study that demonstrated an association of a single nucleotide polymorphism (SNP) in the promoter of this gene with PCOS. Objective: The objective of the study was to replicate the previous report of association between the HSD17B5 gene and PCOS risk by genotyping the promoter SNP (as well as other SNPs in the region to provide improved coverage of the gene) in a large, well-characterized cohort suitable for replication study. Design: Women with and without PCOS were genotyped for five SNPs in HSD17B5. SNPs and haplotypes were determined and tested for association with PCOS risk and phenotypic markers of PCOS. Setting: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; controls were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles. Participants: Participants included 287 white women with PCOS and 187 white controls. Main Measurements: HSD17B5 genotype, PCOS risk, and testosterone levels were measured. Results: No SNP or haplotype was significantly associated with PCOS risk, testosterone, or any of the traits tested. Conclusions: These data suggest that polymorphisms in the HSD17B5 gene are not associated with PCOS risk or elevated testosterone as previously reported.",
author = "Goodarzi, {Mark O.} and Jones, {Michelle R.} and Antoine, {Heath J.} and Marita Pall and Chen, {Yii Der I.} and Ricardo Azziz",
year = "2008",
month = "1",
day = "1",
doi = "10.1210/jc.2007-1712",
language = "English (US)",
volume = "93",
pages = "300--303",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome

AU - Goodarzi, Mark O.

AU - Jones, Michelle R.

AU - Antoine, Heath J.

AU - Pall, Marita

AU - Chen, Yii Der I.

AU - Azziz, Ricardo

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Context: Increased androgen production is a primary feature of polycystic ovary syndrome (PCOS) and appears to be an inherited trait. The gene for the steroidogenic enzyme type 5 17β hydroxysteroid dehydrogenase (HSD17B5) was implicated as a candidate for the hyperandrogenemia of PCOS by a previous study that demonstrated an association of a single nucleotide polymorphism (SNP) in the promoter of this gene with PCOS. Objective: The objective of the study was to replicate the previous report of association between the HSD17B5 gene and PCOS risk by genotyping the promoter SNP (as well as other SNPs in the region to provide improved coverage of the gene) in a large, well-characterized cohort suitable for replication study. Design: Women with and without PCOS were genotyped for five SNPs in HSD17B5. SNPs and haplotypes were determined and tested for association with PCOS risk and phenotypic markers of PCOS. Setting: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; controls were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles. Participants: Participants included 287 white women with PCOS and 187 white controls. Main Measurements: HSD17B5 genotype, PCOS risk, and testosterone levels were measured. Results: No SNP or haplotype was significantly associated with PCOS risk, testosterone, or any of the traits tested. Conclusions: These data suggest that polymorphisms in the HSD17B5 gene are not associated with PCOS risk or elevated testosterone as previously reported.

AB - Context: Increased androgen production is a primary feature of polycystic ovary syndrome (PCOS) and appears to be an inherited trait. The gene for the steroidogenic enzyme type 5 17β hydroxysteroid dehydrogenase (HSD17B5) was implicated as a candidate for the hyperandrogenemia of PCOS by a previous study that demonstrated an association of a single nucleotide polymorphism (SNP) in the promoter of this gene with PCOS. Objective: The objective of the study was to replicate the previous report of association between the HSD17B5 gene and PCOS risk by genotyping the promoter SNP (as well as other SNPs in the region to provide improved coverage of the gene) in a large, well-characterized cohort suitable for replication study. Design: Women with and without PCOS were genotyped for five SNPs in HSD17B5. SNPs and haplotypes were determined and tested for association with PCOS risk and phenotypic markers of PCOS. Setting: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; controls were recruited from the surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles. Participants: Participants included 287 white women with PCOS and 187 white controls. Main Measurements: HSD17B5 genotype, PCOS risk, and testosterone levels were measured. Results: No SNP or haplotype was significantly associated with PCOS risk, testosterone, or any of the traits tested. Conclusions: These data suggest that polymorphisms in the HSD17B5 gene are not associated with PCOS risk or elevated testosterone as previously reported.

UR - http://www.scopus.com/inward/record.url?scp=38149026195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149026195&partnerID=8YFLogxK

U2 - 10.1210/jc.2007-1712

DO - 10.1210/jc.2007-1712

M3 - Article

C2 - 17940109

AN - SCOPUS:38149026195

VL - 93

SP - 300

EP - 303

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -